Cobicistat versus ritonavir as a pharmacoenhancer of atazanavir plus emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV type 1-infected patients: week 48 results. Gallant JE et al, J Infect Dis. 2013 Jul;208(1):32-9 Posted on September 21st, 2013 - Dr Anton Pozniak Back to Home page
Back to Home page